Abstract:Abstract A well-established preclinical model of pancreatic cancer needs to be established to facilitate research on new therapeutic targets. Recently established animal models of pancreatic cancer, including patient-derived tumor models and organoid models, are used for pre-clinical drug testing and biomarker discovery. These models have useful characteristics over conventional xenograft mouse models based on cell lines in preclinical studies, but still cannot accurately predict the clinical outcomes of new treatments and have not yet been broadly implemented in research. We employed pancreatic cancer organoid culture methods using the pancreatic cancer cell line S2-013, and performed pathological and immunohistochemical analyses to characterize tumor xenografts obtained from a mouse model implanted with S2-013 cell line-derived organoids. Serum levels of the pancreatic cancer tumor marker CA19-9 were measured by ELISA. We generated human pancreatic cancer organoids using a co-culture of S2-013 cells, human endothelial cells derived from human umbilical vein endothelial cells, and human mesenchymal stem cells, and established a mouse model with subcutaneously transplanted human pancreatic cancer organoids (S2-013-organoid model). Although blood clotting crater-like formation developed in the middle of subcutaneous xenografts in the S2-013-conventional model, created by subcutaneously injecting S2-013 cells into the right flank of nude mice, the size of xenografts in the S2-013-organoid model gradually increased without crater-like formation. Importantly, tumor xenografts obtained from the S2-013-organoid model exhibited a clinical human pancreatic cancer tissue-like cellular morphology, tissue architecture, and polarity, and actively formed cancer stroma containing mature blood vessels with the high expression of the vascular tight junction marker CD31. In subcutaneous xenografts of S2-013-conventional mice, no blood vessel density or widely expanding areas of necrotic regions were present. Consequently, serum levels of CA19-9 in the S2-013-organoid model correlated with tumor volumes. In addition, epithelial–mesenchymal transition, the conversion of epithelial cells to the mesenchymal phenotype, was observed in tumor xenografts of the S2-013-organoid model. The S2-013-organoid model provides tumor xenografts consisting of clinical human pancreatic cancer-like tissue formation with the effective development of vascularized stroma, and may be valuable for facilitating studies on pre-clinical drug testing and biomarker discovery.

Establishment and evaluation of in vivo model of sciatic neural invasion by PanCa cells in diabetic nude mice

P-0095 Sonic Hedgehog Paracrine Signaling Activates Pancreatic Stellate Cells to Promote The Perineural Invasion of Pancreatic Cancer in Vivo

Comparative Study of Three Methods of Establishing Pancreatic Carcinoma Model in Nude Mice

Establishment of Orthotopic Transplantation Nude Mouse Model with Pancreatic Cancer Celllines CFPAC

Establishment of a Murine Pancreatic Cancer Pain Model and Microarray Analysis of Pain-Associated Genes in the Spinal Cord Dorsal Horn

Perineural invasion in pancreatic cancer:an in vitro study

Establishment of human pancreatic tumor xenograft mouse model for evaluating tumor-homing and gene-silencing effects of siRNA-loading nanoparticles

Hyperglycemic tumor microenvironment induces perineural invasion in pancreatic cancer.

Establishment and Application of Rat Insulinoma Model in Nude Mice

Relationship Between Neural Alteration and Perineural Invasion in Pancreatic Cancer Patients with Hyperglycemia

Subcutaneously Transplanted Human Pancreatic Cancer Tissue Fragments in a Mouse Model

Establishment of Three Human Pancreatic Cancer Orthotopic Xenograft Nude Mice Models and Serum Metabolomics

High‑glucose Microenvironment Promotes Perineural Invasion of Pancreatic Cancer Via Activation of Hypoxia Inducible Factor 1Α.

Stimulation of dorsal root ganglion neurons activity by pancreatic cancer cell lines.

Evaluation of encapsulated pancreatic tumor cells animal model

Sa1717 Role of MicroRNAs in the Interactions Between Pancreatic Stellate Cells and Pancreatic Cancer Cells

Establishment of a pancreatic cancer stem cell model using the SW1990 human pancreatic cancer cell line in nude mice.

Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid

New Insights into Perineural Invasion of Pancreatic Cancer: More Than Pain.

Microencapsulated tumor assay: Evaluation of the nude mouse model of pancreatic cancer

Establishment of an Orthotopic Pancreatic Cancer Mouse Model: Cells Suspended and Injected in Matrigel.